Add new MATech entry – Enable Adherence

[wpseo_breadcrumb]

MATech form

To raise awareness on the diversity of technologies available and the evidence base relevant for decision making, ENABLE is developing an online repository of Medication Adherence Technologies (short: MATech). These may be for example electronic devices that record medication intake, dose dispensers that instruct on time or mode of administration, mobile applications that provide information about a health condition or medication or reminders, etc. You can find more information about the ENABLE repository in the letters of invitation to countries and technology providers.

What is the full name of the MATech as given by its provider?

What is the acronym used for the MATech as given by its provider?

Please describe the MATech briefly (this text will be shown in the short profile of the technology on the repository)

Please provide a link to graphical descriptions of the MATech (photos, illustrations, videos)

What is the level of maturity of the MATech? (Technology Readiness Level, brief description here: https://ec.europa.eu/research/participants/data/ref/h2020/other/wp/2016_2017/annexes/h2020-wp1617-annex-g-trl_en.pdf) Please note that only TLR 4 or higher are eligible for inclusion in the ENABLE repository. If the MATech has not yet reached small scale prototype and you consider its inclusion would be useful, please contact the WG2 Steering Committee for discussion)

In what country is this MATech planned to be included in the ENABLE repository? (Please name the country you are representing in ENABLE, and describe only MATech developed/available in your country. For MATech available across countries, please contact the WG2 Steering Committee to coordinate across countries).

When did the MATech first become available for use? (use the date of publication, release, approval, etc. as you consider appropriate)

When did the most recent version/update of the MATech become available? (e.g. published, released, approved for use, etc.)

What is the identifier (number, name) of the current version of the MATech?

Does the MATech include components of the following types:

Hardware Software Service Material

What is the brand name under which the MATech is made available?

What is the intent of usability for this MATech (or is the MATech intended to be used)?

As a stand-alone solution As a component of a larger solution (if yes, please give details of related components/MATechs in the next field) As a combination (if yes, please give details of the other MATech used and the provider for each MATech in the next field)

Based on the previous question: If the intent of usability for this MATech is as a component of a larger solution or as a combination, please give here the details:

Do any Terms & Conditions apply to the use of this MATech?

Yes (if yes, please detail or provide a link to relevant documents in the next field) No Not applicable Missing

Based on the previous question: If yes, please detail or provide a link to relevant documents

What is the cost of the MATech?

Free Fee required (please detail in the next field)

Based on the previous question: Please detail the price or provide a link to relevant documents:

What is the name of the MATech provider?

Is the MATech provider a:

Privately-owned or for-profit organisation? Public or state-owned organisation? Not-for-profit organisation?

In which domain is the provider active?

Technology Pharmaceutical Healthcare Research and/or education

What contact details should be used for inquiries about, or purchasing/accessing the MATech?

Phone number - specify in next field Address - specify in next field Other - specify in next field

Based on the previous question: Please detail phone number / address / other

The following entries record information about the use scenarios and types of users the technology is intended for, as well as the characteristics of the medication adherence measurement and/or intervention.

Adherence self-management use

These entries refer to scenarios in which the technology is used for adherence self-management activities

Is the MATech intended to be used in activities of self-management, i.e. the patient or informal caregiver or both may use it themselves, for example at home?

Yes No

If yes, who interacts with the MATech within the process of self-management?

Patient Caregiver Other

Based on the previous question: Please detail "other" who interacts with the MATech

The MATech is intended to be used by...

a single person/user (e.g. only one user may interact with the MATech) multiple persons/users (e.g. communication between different users possible via the MATech)

If yes, which age group is the MATech appropriate to be used for?

The technology is appropriate for use by persons with the following level of functioning/impairment in memory functions (registering, storing, retrieving information):

The technology is appropriate for use by persons with the following level of functioning/impairment in perception functions (recognizing and interpreting sensory stimuli):

The technology is appropriate for use by persons with the following level of functioning/impairment in sensory functions - visual stimuli (light, form, shape, size, color):

The technology is appropriate for use by persons with the following level of functioning/impairment in sensory functions - auditive stimuli (presence, location, pitch, loudness and quality of sounds):

The technology is appropriate for use by persons with the following level of functioning/impairment in movement and mobility (of joints, bones, reflexes and muscles):

Is the patient's ability to read and write needed to manage adherence with the MATech?

Yes No Not specified

Is the patient's capacity to obtain, process and understand basic health information and services needed to self-manage adherence with the MATech?

Yes No Not specified

Is the MATech appropriate for patients with complex interactions of several (2+) co-existing diseases (comorbidity)?

Yes No Not specified

Is the MATech appropriate for patients with limited experience with technologies?

Yes No Not specified

These entries refer to scenarios in which the technology is used for activities supporting taking medication in an health/social care provision setting

The technology is intended to be used within an adherence support service, i.e. health/social care professionals may use it to support patients to take medication, for example in a care setting?

If yes, is the MATech intended to be used by professional health and/or social care providers delivering adherence support services?

Yes (if yes, specify in the next field) No

If yes, is the MATech intended to be used by people involved in the administration and oversight of public health systems (health system managers)?

Yes (if yes, specify in the next field) No

These refer to types of diseases or health problems the technology/MATech is intended for.

These entries refer to the prescribed schematic form/ therapeutic plan of medication therapy, thus the type of medication regimen the technology/MATech can be used for

Is the MATech suitable for medication which is prescribed:

Preventively (Medication are prescribed as prevention/prophylaxis against the occurrence of diseases or disease-related adverse events (e.g. exacerbations, organ rejections etc.)) Therapeutically (Medication is prescribed as treatment of a disease and its associated symptoms)?

Is the MATech suitable to be used in:

Short-term treatment(s) (specific time-period, mostly to treat an acute disease of sudden-onset and predictable end) Long-term treatment(s) (prolonged and peristently indicated therapy as it is the case in chronic, latent-progressive disease conditions.)?

Is the MATech suitable to monitor drug administered by:

Is the MATech suitable to be applied for:

Single drug treatment? Polypharmacy (combination therapies)?

Is the MATech suitable to be applied for:

Once-daily doses? Multiple doses in a fixed posology, eg. twice-daily etc.? Once-per-week doses? Multiple dose on certain days per week? The technology is capable to display dose adjustments?

These entries refer to the the medication adherence management types and phases the MATech targets

The MATech is designed to be used to:

Monitor/measure medication adherence (+ comments in the next field) Intervene to support medication adherence (+ comments in the next field)

Based on the previous question: Add comments in this open field

The MATech is designed to be used in the following phases of the adherence process:

Initiation (when the person starts to take the medication prescribed) Implementation (during the period when the person takes the medication prescribed) Discontinuation (when the person stops taking the medication prescribed)

These refer to the way in which information is gathered and summarized by the technology about the patient's medication adherence

If the MATech is used for measurement, what methods does the MATech use to measure adherence?

Direct observation (someone observes the patient's medication intake directly and records it) Pill counts (someone counts the leftover medication after a given period) Self-report Electronic monitoring Electronic healthcare database Laboratory method

These entries refer to the component(s) of the adherence causal (logic) model that is measured by the technology

If the MATech is used for measurement, does it measure…

determinants of behaviour behaviour itself outcomes

If the MATech measures behaviours, which categories of behaviours are included?

if the MATech measures outcomes, which categories of outcomes are included?

clinical (e.g. morbidity, mortality) humanistic (e.g. health-related quality of life, satisfaction) economic (indirect, direct, intangible costs)

These entries aim to describe the ways in which the intervention is delivered to its users.

If the MATech delivers intervention content, which modes of delivery are used?

Printed material Human interaction Electronic Not specified

If the MATech delivers intervention content via printed material, which format is used to deliver it?

Brochure Printed media (e.g. via poster; newspaper or leaflet) Not specified Other

If the MATech delivers intervention content via human interaction, which format is used to deliver it?

Face-to-face consultations Networks and patient groups Not specified Other

If the MATech delivers intervention content via electronic technology, which format is used to deliver it?

Use of a smartphone or tablet (if yes, provide details below) Use of a wearable electronic device (if yes, provide details below) Use of digital media (if yes, provide details below)

If the MATech delivers intervention content via smartphone/tablet, which format is used to deliver it?

If the MATech delivers intervention content via an app, which features does it include?

If the MATech delivers intervention content via digital media, which format is used to deliver it?

This entry refers to the modifiable causal influences on medication adherence (barriers and facilitators) that the MATech targets at the individual level, and the behaviour change techniques in includes to target these determinants.

Please provide a short description of how is the intervention component intended to influence changes in the target behaviour (what techniques it uses, what behavior determinants it aims to change).

This entry refers to the types of persons who use the technology to assist patients in their self-management of adherence.

Is the MATech designed to be used in the following environments:

Telemedicine? Telepharmacy?

This entry refers to the how the MATech has been developed and evaluated, considering aspects such as transparency, theory and evidence base, development guidelines, context compatibility, co-creation, scientific evaluation, reliability and validity of measurement, usability, technical performance, aesthetics, readability, customisation, accessibility, data protection, interoperability, authorisation status. While this information is the object of a more detailed (and optional) MATech description process for interested providers, a brief description would be welcome at this stage.

Please provide a short description of how the MATech has been developed and evaluated, in relation to its specific version and adherence-related content as described above. Please provide links to the key publications and documents accessible online, if appropriate.

Please add your feedback on the data collection form in relation to this MATech. Did you experience any difficulties in collecting information on these topics? Were response options and guidance appropriate? What would be your suggestions for better adapting this form to describing this particular MATech?

MATech form

Adherence self-management use

Read disclaimer before applying